News Snapshot:
The small island nation of Taiwan has high potential as a pharmaceutical manufacturing location. Its highly educated workforce speaks the same language as its neighbor, China, but Taiwan has comparatively more high-value API biologics and injectables capacity for its size. Taiwan has 59 contract manufacturing pharma sites, including 44 with European Medicines Agency (EMA) or FDA approval, and seven sites with Chinese approval. Taiwan has a relatively low COVID-19 infection rate but has failed so far to get the vaccine supplies that it ordered. In July 2021, Taiwanese high-tech giants Foxconn and Taiwan Semiconductor Manufacturing Company (TSMC) donated 10,000,000 doses...
